Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Times Interest Earned (2016 - 2026)

Myriad Genetics has reported Times Interest Earned over the past 16 years, most recently at -$1.3 for Q4 2025.

  • Quarterly Times Interest Earned rose 97.67% to -$1.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$36.88 through Dec 2025, up 16.33% year-over-year, with the annual reading at -$36.88 for FY2025, 16.39% up from the prior year.
  • Times Interest Earned was -$1.3 for Q4 2025 at Myriad Genetics, up from -$6.13 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$1.3 in Q4 2025 and troughed at -$227.4 in Q2 2023.
  • The 5-year median for Times Interest Earned is -$50.67 (2024), against an average of -$61.46.
  • Year-over-year, Times Interest Earned tumbled 666.52% in 2023 and then soared 97.67% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at -$86.2 in 2021, then soared by 32.71% to -$58.0 in 2022, then surged by 39.85% to -$34.89 in 2023, then plummeted by 59.69% to -$55.71 in 2024, then soared by 97.67% to -$1.3 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Times Interest Earned are -$1.3 (Q4 2025), -$6.13 (Q3 2025), and -$219.47 (Q2 2025).